… and what that means for clinical practice, clinical research and cross-site collaboration
Medical imaging is evolving. What used to be a relatively predictable amount of imaging data per patient is now a continuously expanding volume of information. This shift is driven by advances in scanner technology, more complex clinical and research protocols, and the growing role of imaging in longitudinal patient care and clinical trials.
As a result, physicians, researchers, and clinical operations teams increasingly face larger and more complex imaging datasets. These must be stored, shared, and managed across clinical and research workflows.
How imaging data growth is affecting clinical specialities
The impact of larger imaging datasets is visible across nearly all major therapeutic areas.
In cardiology and vascular medicine, imaging has become central to diagnosis, procedural planning, and follow-up. Coronary CT angiography, cardiac MRI, and intravascular imaging techniques such as OCT and IVUS provide highly detailed visualisation of cardiac and vascular anatomy and function. Image quality and procedural requirements continue to advance. But these examinations generate increasingly data-rich studies that must be shared between physicians, hospitals, and industry partners involved in patient care.
In oncology, imaging plays a critical role throughout the patient journey, supporting diagnosis, treatment planning, and response evaluation. Whole-body CT for staging, multiparametric MRI (including diffusion- and perfusion-weighted imaging) for tumour characterisation, and PET/CT or SPECT/CT for metabolic assessment are routinely used. As cancer care becomes more personalised and image-guided, oncology workflows progressively rely on large and information-rich imaging datasets.
In orthopaedics and trauma care, imaging is essential for pre-operative planning, implant positioning, and post-surgical assessment. High-resolution MRI examinations, CT-based surgical planning, and 3D reconstructions are now standard components of many workflows. As surgical planning becomes increasingly digital and image-driven, orthopaedic procedures generate larger and more structured imaging datasets than in the past.
In neurology, advanced imaging techniques are routinely used to evaluate brain structure, function, and disease progression. High-resolution structural MRI, diffusion-weighted imaging, functional MRI, PET and SPECT imaging all contribute valuable diagnostic information across conditions such as neurodegenerative diseases, epilepsy, and brain tumours. These examinations often involve complex imaging protocols that generate substantial amounts of data for interpretation and collaboration.
Clinical trials, AI-assisted imaging and quantitative biomarkers
Advances in clinical practice contribute to larger imaging datasets; the evolution of clinical research itself introduces another layer of complexity.
Modern clinical trials collect substantially more imaging data than in the past. In imaging-intensive therapeutic areas, medical imaging is no longer limited to baseline and endpoint assessments. It has become a core analytical and regulatory component of clinical development. Many studies now include multiple imaging timepoints throughout patient follow-up. This leads to longitudinal datasets that must be consistently managed across sites and study phases.
Blinded independent central review (BICR) and independent central image review (ICIR) have become standard in many imaging-heavy therapeutic areas. Clinical sites transfer imaging datasets to imaging core labs or independent reviewers, where they are standardised, evaluated, and often re-annotated. Multiple reads, adjudication workflows, and longitudinal comparisons are frequently performed on the same dataset.
In parallel, AI-assisted image analysis has introduced new requirements for data completeness and consistency. AI models depend on high-quality, well-structured imaging datasets and complete image series rather than partial exports or compressed subsets. This increases both storage requirements and data transfer demands.
Quantitative imaging biomarkers further amplify this trend. They enable measurement of endpoints, for example, tumour burden, lesion response metrics, and volumetric changes. This makes consistency and completeness of imaging datasets critical across multi-site studies. Often, these biomarkers also require multi-sequence, multi-phase, or timepoint-specific imaging data. As a consequence, the dataset volume grows from the moment medical images are acquired.
Particularly in large-scale clinical trials, individual imaging datasets can easily reach multi-gigabyte sizes per patient. This is particularly the case in multiphase CT or multiparametric MRI workflows.
Beyond primary study analysis, centralised and annotated imaging datasets are increasingly reused for secondary applications. These include simulation studies, medical device refinement, surgical planning, and training AI-based image analysis tools.
Together, these developments have turned medical images from a diagnostic resource into a long-term research asset. As a result, storage, transfer, and collaboration requirements continue to grow across clinical research environments.
Why this matters for clinical workflows and research infrastructure
As medical imaging datasets continue to grow, the challenge is no longer limited to image acquisition or interpretation. It increasingly concerns how imaging data is shared, managed and made available across organisations and stakeholders.
Physicians rely on imaging data for referrals, second opinions, interdisciplinary case discussions, and pre-surgical planning. Researchers require complete datasets to ensure reproducibility and robust analysis. Clinical trial teams depend on standardised imaging workflows between clinical sites and central imaging environments. At the same time, regulatory and privacy requirements demand secure handling and anonymisation of patient data in medical images.
In many organisations, these requirements ultimately translate into the need for secure and efficient DICOM (Digital Imaging and Communications in Medicine) image exchange across institutions, research sites, and clinical stakeholders.
As a result, central imaging infrastructure is becoming as important as imaging technology itself. The ability to reliably exchange, store and manage large image datasets is now a core requirement for modern clinical research and healthcare collaboration.
ClinFlows perspective: enabling scalable imaging data exchange
If imaging datasets grow, infrastructure must evolve accordingly.
ClinFlows provides solutions for DICOM image exchange in real-world clinical and research workflows.
With dicomdrop, users can transfer zipped DICOM datasets of up to 10 GB per upload, enabling efficient sharing of large imaging files without requiring additional infrastructure.
For larger-scale projects, decidemedical provides a vendor-neutral imaging hub for structured, role-based collaboration across institutions, studies, and global research networks, with no practical limitation on data volume or imaging modality.
Both solutions are built around a shared principle: they enable secure, reliable, and privacy-conscious exchange of medical imaging data while adapting to the increasing size and complexity of modern imaging workflows.
Conclusion
Imaging datasets are becoming larger because medical imaging itself is evolving.
Higher spatial resolution, multi-parametric and multi-modality imaging, longitudinal clinical trial designs, and the increasing use of images in secondary applications are collectively driving sustained growth in data volume.
This is not a temporary trend. It is a structural shift in how medical imaging is created, used, and shared across clinical practice and research.
Ultimately, healthcare providers, researchers, and life science organisations face a shared challenge: ensuring that the infrastructure for exchanging and managing medical imaging evolves at the same pace as the imaging technologies that generate it.
